PB

Payalben Babubhai Gadhe

Active Director Director DIN 11564032
DIN 11564032 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Payalben Babubhai Gadhe

Data last updated:

Payalben Babubhai Gadhe is a Director at Zycorex Pharma Private Limited (since 2026). The company operates in Pharma.

DIN 11564032
Primary Designation Director
Industry Pharma
First Appointment 22 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zycorex Pharma Private Limited U21000GJ2026PTC174010
Director22 Feb 20262026Active

Board colleagues of Payalben Babubhai Gadhe

Directorship timeline

Open interactive timeline →
Zycorex Pharma Private Limited
Premium access

Shareholding and investment profile for Payalben Babubhai Gadhe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payalben Babubhai Gadhe

Payalben Babubhai Gadhe currently holds 1 directorship: Zycorex Pharma Private Limited (Director, since 22 Feb 2026).

Payalben Babubhai Gadhe was first appointed on 22 Feb 2026 as Director at Zycorex Pharma Private Limited.

The current boards of Payalben Babubhai Gadhe's companies include Meet Manishbhai Vadher (Zycorex Pharma Private Limited), Vijay Vajasibhai Borkhatria (Zycorex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available